Chairman of the Covid Strategy Group, CSIR, Dr Ram Vishwakarma said that Emergency Use Authorisation for the Merck drug Molnupiravir is likely within days.
#AntiCovidPill #Molnupiravir #CovidVaccine #Merck
Chairman of the Covid Strategy Group, CSIR, Dr Ram Vishwakarma said that Emergency Use Authorisation for the Merck drug Molnupiravir is likely within days.
#AntiCovidPill #Molnupiravir #CovidVaccine #Merck